Delivery Order SPE2DB20D1102-SPE2DB24FC6TD

Award Date 8/2/24
Potential Completion Date 8/5/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, to provide TOBRADEX eye ointment. The $1,777.39 contract has a completion date of February 16, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance...
This is a $2,545.89 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TOBRADEX EYE OINTMENT 3.5GM, with a completion date of February 13, 2023. The contract type is Firm Fixed Price. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which...
This federal contract award, valued at $1,082.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TOBRADEX EYE OINTMENT 3.5GM, a medical product used for eye care. The contract has an ultimate completion date of January 28, 2025 and is structured as a Firm Fixed Price Delivery Order. This award does not have a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of TOBRADEX EYE OINTMENT 3.5GM. The award, valued at $5,434.91, is a Firm Fixed Price Delivery Order contract with a period of performance through January 6, 2025. AmerisourceBergen, a major pharmaceutical distributor, is providing these medical supplies to support military healthcare programs. The contract is not designated as a set-aside award. In addition to this...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $2,767.50 Firm Fixed Price Delivery Order is for the supply of 4564657159 - Tobradex Eye Ointment 3.5 grams. The contract has an ultimate completion date of May 21, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor. The $1,960.84 firm fixed price delivery order is for the supply of TOBRADEX Eye Ointment, a prescription medication, to support government healthcare programs. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary...
This federal contract award, valued at $9,795.17, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TOBRADEX EYE OINTMENT 3.5GM to the government. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves...
This federal contract award, SPE2DB22D1041|SPE2DB25FTYL6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,981.26 firm fixed-price delivery order is for the supply of TOBRADEX EYE OINTMENT 3.5GM to support military and federal healthcare programs. The contract has an ultimate completion date of November 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The $3,142.34 order is for the supply of TOBRADEX EYE 3.5GM 1S, a pharmaceutical product, with a completion date of January 26, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC)...
This federal contract award is for the delivery of TOBRADEX eye ointment to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that specializes in supplying medical products to federal government agencies. The contract award, valued at $3,826.33, is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop...
  • SPE2DB20D1102
    Indefinite Delivery Contract
  • SPE2DB20D1102-SPE2DB24FC6TD
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $1,092.56 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of 4,565,330,497 units of TOBRADEX Eye Ointment 3.5GM. This delivery order contract falls under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a wide range of pharmaceutical and medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside designation and is expected to be completed by August 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by various defense and civilian agencies to supply critical medical supplies and prescription drugs.

Generated 11/1/24, 9:55 AM